BlackRock Fund Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$62M Buy
2,258,531
+536,583
+31% +$21.6M 0.01% 1543
2016
Q3
$106M Buy
1,721,948
+116,101
+7% +$3.51M 0.02% 1013
2016
Q2
$30.6M Sell
1,605,847
-55,971
-3% -$1.04M 0.01% 1792
2016
Q1
$32.4M Buy
1,661,818
+36,371
+2% +$635K 0.01% 1713
2015
Q4
$62.7M Buy
1,625,447
+55,431
+4% +$1.8M 0.01% 1317
2015
Q3
$50.4M Buy
1,570,016
+41,183
+3% +$1.4M 0.01% 1417
2015
Q2
$46.5M Sell
1,528,833
-32,159
-2% -$658K 0.01% 1574
2015
Q1
$20.7M Buy
1,560,992
+45,301
+3% +$604K 0.01% 2049
2014
Q4
$21.9M Buy
1,515,691
+134,357
+10% +$2.28M 0.01% 2019
2014
Q3
$29.1M Sell
1,381,334
-9,310
-0.7% -$210K 0.01% 1721
2014
Q2
$41.4M Sell
1,390,644
-18,970
-1% -$600K 0.01% 1524
2014
Q1
$33.9M Buy
1,409,614
+46,461
+3% +$1.18M 0.01% 1683
2013
Q4
$27.8M Buy
1,363,153
+136,242
+11% +$4.05M 0.01% 1790
2013
Q3
$57.9M Buy
1,226,911
+209,318
+21% +$8.06M 0.02% 1210
2013
Q2
$38.7M Buy
+1,017,593
New +$36.4M 0.01% 1416

Other funds holding SRPT